NDC 50090-6087-01 - Levothyroxine sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6087
- Requested NDC
- 50090-6087-01
- Package NDCs from labels
- 50090-6087-1, 50090-6087-0, 50090-6087-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-02-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine sodium - A-S Medication Solutions | A-S Medication Solutions | 2026-02-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6087-0 | Levothyroxine sodium | 30 in 1 BOTTLE | TABLET | 30 | 10 | |
| 50090-6087-1 | Levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6087 | LEVOTHYROXINE SODIUM TABLET [A-S MEDICATION SOLUTIONS] | 4 | Current NDC, Legacy NDC, 2 package rows | 20231128_b717aff6-f754-458d-be87-d12d87c5da00.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6087-0 | EA - Each | 50090-6087 | b7b0a8bc-23d1-4fc4-b70d-5a0ccba5438d | 1 | 2022-10-06 |
| 50090-6087-1 | EA - Each | 50090-6087 | 3ea1ef6b-a243-4019-aa6b-505b35dc2742 | 1 | 2022-10-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 2ecaa38f-8a6f-4536-8033-251d2c52ae64 | 2026-03-30 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 4461bc9f-35db-4211-82ab-7671cf4dc14b | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 66bb0ba9-cd63-4817-907f-7b8ad5dc6685 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| Tirosint SOL | LEVOTHYROXINE SODIUM | IBSA Pharma Inc. | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | a0fa8fa5-d3bd-4e52-9ec5-5fb84702826d | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966224 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 70853a82-ba3b-4663-9f78-6791ca72ba9f | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966224 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 8ac112c3-1e06-4fdb-a7af-2ee988de5b15 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 69fb5cd6-90ba-487d-a754-07c664a1fdd1 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| Magnesium Oxide | MAGNESIUM OXIDE | Bryant Ranch Prepack | f98cac25-63f2-478e-b785-20cba1c56565 | 2026-03-27 | Warnings | 3A3U0GI71G |
| Tirosint | LEVOTHYROXINE SODIUM | IBSA Pharma Inc. | 7a7ade79-0165-4e31-b84e-667416c00c7e | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | YARAL Pharma Inc. | d28d7202-1278-0486-e053-2995a90af286 | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 7c8a6441-3c12-46ae-bb3b-a320d80045b6 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966249 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 008de8fd-150f-4022-8ccb-c8bfa94875c7 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966249 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 991399a4-ff94-44d0-b1ba-1f89e7759498 | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 87333260-fe57-4d99-886c-7c66cb063898 | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 52a07ade-4098-477d-874e-dd692667041e | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 67f46137-afc4-471b-a6c7-9c2aef92da5d | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | ANDA212399 892251 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | PD-Rx Pharmaceuticals, Inc. | 70a9bb5c-2259-405e-8d89-cc1db8c70743 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966221 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | PD-Rx Pharmaceuticals, Inc. | 6f4998ac-0714-4f5d-8944-9e6902b9f0a6 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | ANDA212399 892246 9J765S329G |
| Folartex | MULTIVITAMIN | Oncora Pharma, LLC | 0a4cb0ab-565f-45e8-a989-740bccef21cd | 2026-02-25 | Warnings, Adverse reactions | 3A3U0GI71G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.